{"title":"癌症母婴传播:分子肿瘤检测、免疫调节和儿科恶性肿瘤的意义。","authors":"Ramez N Eskander, Razelle Kurzrock","doi":"10.1016/j.medj.2021.02.006","DOIUrl":null,"url":null,"abstract":"<p><p>Molecular tumor testing has transformed the treatment of patients with malignancies and is helping catalyze the development of novel therapeutic strategies. In a recent issue of <i>The New England Journal of Medicine</i>, Arakawa et al. describe two cases of pediatric lung cancer resulting from mother-to-infant transmission, diagnosed remote from delivery.<sup>1</sup>.</p>","PeriodicalId":272244,"journal":{"name":"Med (New York, N.y.)","volume":" ","pages":"211-213"},"PeriodicalIF":0.0000,"publicationDate":"2021-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.medj.2021.02.006","citationCount":"1","resultStr":"{\"title\":\"Maternal to fetal transmission of cancer: implications for molecular tumor testing, immune regulation, and pediatric malignancies.\",\"authors\":\"Ramez N Eskander, Razelle Kurzrock\",\"doi\":\"10.1016/j.medj.2021.02.006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Molecular tumor testing has transformed the treatment of patients with malignancies and is helping catalyze the development of novel therapeutic strategies. In a recent issue of <i>The New England Journal of Medicine</i>, Arakawa et al. describe two cases of pediatric lung cancer resulting from mother-to-infant transmission, diagnosed remote from delivery.<sup>1</sup>.</p>\",\"PeriodicalId\":272244,\"journal\":{\"name\":\"Med (New York, N.y.)\",\"volume\":\" \",\"pages\":\"211-213\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-03-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.medj.2021.02.006\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Med (New York, N.y.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.medj.2021.02.006\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Med (New York, N.y.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.medj.2021.02.006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Maternal to fetal transmission of cancer: implications for molecular tumor testing, immune regulation, and pediatric malignancies.
Molecular tumor testing has transformed the treatment of patients with malignancies and is helping catalyze the development of novel therapeutic strategies. In a recent issue of The New England Journal of Medicine, Arakawa et al. describe two cases of pediatric lung cancer resulting from mother-to-infant transmission, diagnosed remote from delivery.1.